“Powerless.” Right. The same woman who dragged a 10-patient academic pilot through a 331-patient, placebo-controlled, double-blind Phase 3 in glioblastoma while surviving short attacks, NIH gatekeeping, an SEC case, and a global pandemic.
The same woman who built GMP manufacturing from scratch on two continents, automated it, and filed a marketing application for a personalized cell therapy before big pharma even figured out how to spell “PICV.”
But yeah, let’s ignore all that because in 2011 she said 18–24 months and it turned into 14 years. Meanwhile, Pfizer’s out here paying $43 billion for Seagen and still doesn’t have a glioblastoma plan.
Timing is fair game. Disrespect isn’t. You don’t have to like her but pretending this was a nothingburger company run by a clueless lawyer just makes you look unserious.
Bullish
Market Data 
Markets 
AI
